KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 142 filers reported holding KURA ONCOLOGY INC in Q4 2022. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $537,123 | -12.4% | 58,895 | +1.6% | 0.00% | – |
| Q2 2023 | $613,471 | -16.5% | 57,984 | -3.5% | 0.00% | – |
| Q1 2023 | $735,036 | -14.5% | 60,101 | -13.2% | 0.00% | – |
| Q4 2022 | $859,665 | -9.2% | 69,272 | -0.1% | 0.00% | – |
| Q3 2022 | $947,000 | -28.1% | 69,311 | -3.6% | 0.00% | – |
| Q2 2022 | $1,317,000 | +30.9% | 71,905 | +14.9% | 0.00% | – |
| Q1 2022 | $1,006,000 | -96.0% | 62,597 | -96.5% | 0.00% | -100.0% |
| Q4 2021 | $25,210,000 | -55.1% | 1,800,627 | -40.0% | 0.01% | -57.1% |
| Q3 2021 | $56,194,000 | +76.8% | 3,000,140 | +96.8% | 0.01% | +75.0% |
| Q2 2021 | $31,792,000 | -33.7% | 1,524,790 | -10.1% | 0.01% | -38.5% |
| Q1 2021 | $47,924,000 | +418.7% | 1,695,212 | +499.2% | 0.01% | +333.3% |
| Q4 2020 | $9,240,000 | -3.2% | 282,917 | -9.2% | 0.00% | 0.0% |
| Q3 2020 | $9,548,000 | +201.4% | 311,604 | +79.0% | 0.00% | +200.0% |
| Q2 2018 | $3,168,000 | +116.0% | 174,074 | +122.5% | 0.00% | 0.0% |
| Q1 2018 | $1,467,000 | – | 78,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |